Dynavax Technologies
DVAX
#5494
Rank
HK$10.01 B
Marketcap
HK$85.32
Share price
-0.09%
Change (1 day)
-14.97%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$3.21 Billion

According to Dynavax Technologies 's latest financial reports the company's total liabilities are HK$3.21 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$3.02 B3.23%
2023-12-31HK$2.92 B-7.4%
2022-12-31HK$3.16 B-50.34%
2021-12-31HK$6.36 B178.92%
2020-12-31HK$2.28 B8.29%
2019-12-31HK$2.10 B82.18%
2018-12-31HK$1.15 B670.22%
2017-12-31HK$0.15 B-5.36%
2016-12-31HK$0.15 B-30.67%
2015-12-31HK$0.22 B-21.89%
2014-12-31HK$0.29 B106.34%
2013-12-31HK$0.14 B-26.44%
2012-12-31HK$0.19 B-27.31%
2011-12-31HK$0.26 B6.28%
2010-12-31HK$0.25 B-26.85%
2009-12-31HK$0.34 B-40.59%
2008-12-31HK$0.57 B-9.24%
2007-12-31HK$0.63 B242.27%
2006-12-31HK$0.18 B316.97%
2005-12-31HK$44.42 M-58.48%
2004-12-31HK$0.10 B-84.45%
2003-12-31HK$0.68 B0.45%
2002-12-31HK$0.68 B77.37%
2001-12-31HK$0.38 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
HK$4.00 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.63 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$604.39 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$288.63 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$533.13 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
HK$477.08 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
HK$900.18 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$253.79 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$626.83 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA